Table 2. Genetic characterization of VU-DIPG-3 and -5 human tumors and murine xenografts.
VU-DIPG-3 | VU-DIPG-5 | |||
---|---|---|---|---|
human | murine | human | murine | |
Specific mutation | ||||
H3F3A K27M | + | − | + | − |
H3F3A G34R | − | − | − | − |
HIST1H3B K27M | − | − | − | − |
PI3KCA H1047R | − | − | − | − |
PI3KCA H1047L | − | − | − | − |
PI3KCA E542K | − | − | − | − |
Amplification | ||||
EGFR | − | − | n.a. | n.a. |
PTEN | − | − | Deletion | n.a. |
PDGFR-α | − | − | n.a. | n.a. |
Array CGH profile | ||||
Human 180K | Gain 1q, loss 17p (distal) | n.a. | n.a. | n.a. |
Mouse 180K | n.a. | Loss 4 (C4-C5), gain 4 (C5-D2.2) | n.a. | n.a. |